| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 6.4× | −1.7× | |
| Price / Book | 1.3× | 2.0× | |
| Price / Sales | 116.6× | 3.9× | |
| Price / Free cash flow | −97.1× | −1.5× | |
| EV / EBITDA | 6.4× | −1.2× | |
| Earnings yield | 15.6% | −14.4% | |
| Free cash flow yield | −1.0% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,297.71 | +4.63% | $1.22T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $260.52 | +2.65% | $627.83B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.82 | +2.17% | $510.38B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $418.09 | +2.76% | $375.28B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.27 | +3.23% | $365.81B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.83 | +1.75% | $281.74B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.38 | +2.70% | $261.14B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $682.35 | +0.44% | $252.3B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $436.26 | +2.66% | $235.86B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.60 | +1.65% | $192.94B | 22.3× | 37.5% | +29.9% |
